BioCentury
ARTICLE | Clinical News

EndoBarrier Gastrointestinal Liner regulatory update

October 25, 2010 7:00 AM UTC

GI Dynamics received CE Mark approval in Europe for its EndoBarrier Gastrointestinal Liner to treat obesity and Type II diabetes for up to 12 months. The product, which is a non-surgical liner placed ...